Bcal Diagnostics Ltd (BDX) — Cash Flow Reinvestment Rate
Latest as of December 2020:
0.02x
Bcal Diagnostics Ltd (BDX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2020, reinvesting AU$1.93K (capex AU$1.93K ) from operating cash flow of AU$118.98K. Explore reinvestment intensity of Bcal Diagnostics Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
AU$1.93K
Capex + Investments
Operating Cash Flow
AU$118.98K
AUD
Capital Expenditures
AU$1.93K
AUD
Annual Cash Flow Reinvestment Rate for Bcal Diagnostics Ltd (None–None)
Year-by-year capital reinvestment analysis for Bcal Diagnostics Ltd. For live market cap and broader valuation context, see Bcal Diagnostics Ltd (BDX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow